Timo Vesikari

Medicine · Health Sciences

67h-index20.2kcitations349works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(218), Viral Infections and Immunology Research(111), Animal Virus Infections Studies(91), Hepatitis Viruses Studies and Epidemiology(59), Respiratory viral infections research(57)

Publications347 total

PreHevbrio: the first approved 3-antigen hepatitis B vaccine
Expert Review of Vaccines·2023· 16 citedOpen Access
T-cell responses to PreS1 and PreS2 are correlated to anti-HBs antibody titres, which are higher and persist longer in volunteers vaccinated with 3-antigen than with 1-antigen hepatitis B vaccine in the PROTECT Study: 3.5 year follow-up
Journal of Hepatology·2023· 1 cited
The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine
Vaccine·2023· 12 citedOpen Access
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
Journal of the Pediatric Infectious Diseases Society·2023· 14 citedOpen Access
Viral Gastroenteritis: Sickness Symptoms and Behavioral Responses
mBio·2023· 16 citedOpen Access
Long term persistence of anti-HBs antibodies after vaccination with a 3-antigen HBV vaccine compared to a single-antigen HBV vaccine
Journal of Hepatology·2022
Trimeric S protein COVID-19 vaccine needs to find its place
The Lancet·2022· 1 citedOpen Access
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine
JAMA Network Open·2021· 59 citedOpen Access
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)
UNC Libraries·2021Open Access
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
The Lancet Infectious Diseases·2021· 70 cited
Human Protoparvovirus DNA and IgG in Children and Adults with and without Respiratory or Gastrointestinal Infections
Viruses·2021· 20 citedOpen Access
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT)<i>vs</i>. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
Epidemiology and Infection·2021· 20 citedOpen Access
Rotavirus Vaccine
2021
Norovirus Vaccines in Pipeline Development
2021
Influenza Vaccines
2021· 1 cited
Pediatric Vaccines and Vaccinations
2021· 5 cited
Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies
Vaccine·2020· 4 citedOpen Access
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials
The Lancet·2020· 183 cited
1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
Open Forum Infectious Diseases·2020Open Access
8. Higher hepatitis B antibody titres induced in all adults vaccinated with a tri-antigenic hepatitis B (HBV) vaccine, compared to a mono-antigenic HBV vaccine: results from two pivotal phase 3 double-blind, randomized studies (PROTECT and CONSTANT)
Open Forum Infectious Diseases·2020Open Access
page 1 of 18Next →

Frequent Co-authors

Aino Karvonen(10), A. Delem(6), Michael J. Dallas(5), Leena Huhti(5), Vesna Blazevic(5), Pierre Van Damme(4), Michelle G. Goveia(4), Penny M. Heaton(4), Béatrice De Vos(4), Erika Isolauri(4), Suvi Lappalainen(4), Robbin Itzler(3), Ralf Clemens(3), Marjo Salminen(3), Tiina Korhonen(3), Carlo Giaquinto(3), David O. Matson(2), Mathuram Santosham(2), Steven Black(2), C D C Christie(2)